Orbimed Advisors Llc sold $4.9M of Corvus Pharmaceuticals (CRVS)

Executed Jun 27 2025, disclosed Jul 1 2025, 4 days later.

Value, as filed

$4.9M

1,176,332 sh × $4.16

Executed

Jun 27 2025

the trade date, as filed

Disclosed

Jul 1 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 15 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

CRVS

Corvus Pharmaceuticals, Inc. CRVS · Healthcare · 3 filings in 24 months ticker →

Healthcare · Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely t…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→